![]() Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. | ![]() Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. | |
Founding Date | Founding Date 2016 | Founding Date 2014 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US | Locations London, GB HQ London, GB |
Employees | Employees 851% decrease | Employees 647 |
Financial | ||
Revenue (est.) | Revenue (est.) kr74.2m (FY, 2021) | Revenue (est.) $75.4m (FY, 2025) |
Cost of goods | Cost of goods kr40.2m (FY, 2021) | Cost of goods $86.6m (FY, 2025) |
Gross profit | Gross profit kr34.1m (FY, 2021) | Gross profit ($10.7m) (FY, 2025) |
Net income | Net income (kr27.4m) (FY, 2021) | Net income ($287.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 4.1m | Total funding raised $ 281.7m |

Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View company